Compass Financial Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.16M Buy
12,072
+912
+8% +$234K 0.34% 71
2026
Q2
$2.76M Buy
+11,160
New +$2.4M 0.33% 79

Other funds holding ABBV

Compass Financial Management's ABBV Position: Q3 2026 in Review

Compass Financial Management increased its AbbVie (ABBV) stake by 8.2% in Q3 2026, buying an estimated $234K and bringing the position to 12,072 shares worth $3.16M. The position accounts for 0.34% of the portfolio, ranked #71.

Compass Financial Management first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Compass Financial Management held 12,072 shares of AbbVie worth $3.16M as of Q3 2026.
  • Compass Financial Management bought 912 AbbVie shares in Q3 2026, an estimated $234K.
  • AbbVie made up 0.34% of Compass Financial Management's portfolio in Q3 2026, its #71 holding.
  • Compass Financial Management first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.